Olivier Bohuon

Olivier Bohuon
Olivier Bohuon
Born	Olivier Jean Bohuon; 3 January 1959; Paris, France
Nationality	French
Alma mater	HEC Paris; University of Paris-Sud
Occupation	Businessman
Years active	1970–present
Title	CEO, Smith & Nephew plc
Term	2011–2018
Predecessor	David Illingworth
Successor	Namal Nawana
Spouse(s)	Alexandra Polliot
Children	2 sons, 1 daughter
Parent(s)	Claude Bohuon; Odile Guinnebault

Olivier Jean Bohuon (born 3 January 1959) is a French businessman. He was the chief executive (CEO) of Smith & Nephew plc, a British multinational medical equipment manufacturing company.

Early life

Olivier Bohuon was born on 3 January 1959 in Paris.[1] He is the son of Claude Bohuon and Odile Guinnebault.[1]

Bohuon earned a doctorate in pharmacy from University of Paris-Sud in 1982 and a master in business administration from HEC Paris in 1985.[1][2]

Career

Bohuon was the chief executive of Smith & Nephew plc and Smith & Nephew Inc from April 2011 until May 2018.[3] He served as the chief executive of Laboratoires Pierre Fabre from September 2010. Before that, he worked for Abbott Laboratories from 2003 to July 2010, rising to executive vice president, pharmaceutical products.

Bohuon served as senior vice president, director of European Commercial operations at GlaxoSmithKline from 2001 to 2003. He served as CEO and then president of SmithKline Beecham France from 1995 to 2001. He was the marketing director and then the operations director of Glaxo France from 1991 to 1995. He worked for Abbott Laboratories from 1988 to 1991.

Bohuon is a director of HealthCare Promise Investments Partners SA (Luxembourg). He is a member of the supervisory board at Virbac SA. He is a member of the National Pharmacy Academy and the Academy of Technologies.[4] Since August 2018, Bohuon is vice chairman of the Board of Directors of healthcare and pharma company LEO Pharma.[5]

Bohuon became a Knight of the Legion of Honour in 2007.[1]

Personal life

Bohuon married Alexandra Polliot in 1981.[1] They have two sons and a daughter.[1]

In February 2016, Smith & Nephew said Bohuon had a "highly treatable form of cancer."[6][7]

References

"BOHUON, Olivier Jean". Who's Who 2017. Oxford University Press. Retrieved 11 September 2017.
"The business on...Olivier Bohuon, Chief executive, Smith & Nephew". The Independent. 5 November 2011. Retrieved 21 November 2012.
"Namal Nawana appointed Chief Executive Officer of Smith & Nephew | Smith & Nephew". www.smith-nephew.com. Retrieved 2018-10-03.
"Olivier Bohuon: Executive Profile". BusinessWeek. Retrieved 21 November 2012.
"Olivier Bohuon Elected to LEO Pharma's Board of Directors". Retrieved 2018-10-03.
Brown, John Murray (February 1, 2016). "Smith & Nephew chief Olivier Bohuon has 'highly treatable' cancer". Financial Times. Retrieved 11 September 2017.
Bradshaw, Julia (1 February 2016). "Smith & Nephew boss reveals cancer diagnosis". The Daily Telegraph. Retrieved 11 September 2017.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[whoswhobio-1] "BOHUON, Olivier Jean". Who's Who 2017. Oxford University Press. Retrieved 11 September 2017.

[2] "The business on...Olivier Bohuon, Chief executive, Smith & Nephew". The Independent. 5 November 2011. Retrieved 21 November 2012.

[3] "Namal Nawana appointed Chief Executive Officer of Smith & Nephew | Smith & Nephew". www.smith-nephew.com. Retrieved 2018-10-03.

[4] "Olivier Bohuon: Executive Profile". BusinessWeek. Retrieved 21 November 2012.

[5] "Olivier Bohuon Elected to LEO Pharma's Board of Directors". Retrieved 2018-10-03.

[ftsmithandnephewchiefolivier-6] Brown, John Murray (February 1, 2016). "Smith & Nephew chief Olivier Bohuon has 'highly treatable' cancer". Financial Times. Retrieved 11 September 2017.

[dailytelegraphbossreveals-7] Bradshaw, Julia (1 February 2016). "Smith & Nephew boss reveals cancer diagnosis". The Daily Telegraph. Retrieved 11 September 2017.